February 5-6, 2024 – North Bethesda, MD
The Accelerating Medicines Partnership® (AMP®) Program was launched in February 2014 to bring together the resources and expertise of both the National Institutes of Health (NIH) and the private sector to solve pressing challenges in various diseases and disease areas. The AMP program, managed by the FNIH, is comprised of projects with a common goal of accelerating the process of bringing new and effective therapies to patients and operates under the broad principle of delivering pre-competitive advancements to the research and medical fields to enable broad access and use of AMP research discoveries. Originally focused on three specific diseases, the program has since grown to 10 individual projects representing the contributions and participation of 16 NIH institutes and over 70 private sector partners.
This inaugural scientific symposium celebrated the 10th anniversary of the program, highlighted successful innovation and collaboration in each of the individual AMP project areas, and provided a forum for discussions and cross-collaboration in the broader AMP research community.
Written proceedings coming soon
Day 1No slides for this session |
Day 2No slides for this session |
No slides for this session |
No slides for this session |
No slides for this session |
No slides for this session |
No slides for this session |
Contact
For more information about the AMP Program, please contact
Courtney Silverthorn, Ph.D.
Associate Vice President, Science Partnerships
[email protected]